Sign up for The Daily Upside to
brian@thedailyupside.com
Brian Boyle (he/him) is Lead Reporter at The Daily Upside. His writing has previously appeared in outlets such as Vice, Slate, and The Los Angeles Times, where he was a contributing writer on the opinion section. He lives in Los Angeles.
Sign up for The Daily Upside to get clarity on the news shaping the market delivered straight to your inbox. For free.
Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Blue Origin is expected to back out of plans to build a commercial space station in conjunction with corporate partners.
On Monday, Rivian announced an expectations-beating jump in deliveries for its third quarter. But a new report says it’s still losing money.
Snap shuttered its ARES unit — that’s Augmented Reality for Enterprise Services — after launching it just a few months ago.
On Tuesday, the S&P 500 and the Nasdaq 100 both sank to their lowest respective levels in three months. What has investors so anxious?
The US State Department announced a low-interest $2 billion direct loan agreement to help Poland modernize its defense program.
McDonald’s has had a tenuous relationship with its franchise operators as of late. A new round of royalty fee hikes isn’t likely to help.
Solaris was once a rising star in the fintech world. Now its sweating to raise 100 million euros to fund a major client project.
If Hollywood studios want to settle the current dual strike, they may have to get much more open about just how popular their shows are.
Unfortunately for the Lachlan Murdoch there is not much by way of peace in the kingdom, and indications are this may be a short reigns.